7 May 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has revealed the keynote speakers for its flagship event, Drug Discovery 2025. Taking place at the ACC in Liverpool, UK from 21–22 October, the conference will feature presentations from Professor Heather Pinkett (Northwestern University) and Dr Dafydd Owen (Pfizer Medicine Design).

6 May 2025 -- Valby, Denmark -- H. Lundbeck A/S is pleased to announce its agreement with the Danish Centre for AI Innovation (DCAI), the company established to run and operate Gefion, Denmark’s flagship AI supercomputer. Lundbeck is one of the first pharmaceutical companies to leverage Gefion to accelerate drug discovery and development in neurological and psychiatric disorders.

6 May 2025 -- Nebraska, US -- Celerion, a global leader in early clinical research and bioanalytical services, announced the launch of the latest version of Labnotes, its cutting-edge bioanalytical electronic laboratory notebook software elevating data handling and analysis capabilities for sponsors.

1 May 2025 -- Ontario, Canada -- Alimentiv and Dova Health Intelligence™ (formerly Satisfai Health) are announcing the commercial availability of Dova Health’s DovaVision™, an AI-powered dynamic frame-level Mayo Endoscopic Sub-score (MES) feature analysis solution of endoscopy videos, providing adjunct AI-reads for Phase I through IV UC clinical trials.

25 April 2025 -- Durham, NC and Männedorf, Switzerland -- BioSkryb Genomics and Tecan Group today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan.

24 April 2025 -- Eschborn, Germany -- AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has introduced Redipor ready-to-use culture media as an AnalytiChem branded product line globally.

22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).

Join the UK’s leading biotechnology event to explore groundbreaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for 𝐅𝐑𝐄𝐄.

14 April 2025 -- Cambridge, UK and Massachusetts, US -- Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery system, today announced the addition of a new membrane protein workflow to its system.

11 April 2025 -- Birmingham, UK -- In the latest episode of the Aston Originals podcast What is a membrane?, Dr Emma Shepherd, Dr Dominic Mosses and Dr David Jenkins join host Dr Matt Derry to explain the workings and potential of Aston University’s Quantum X bio printer.

8 April 2025 -- Osaka, Japan -- Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) presents new European data from its largest real-world evidence study of Fetroja®/Fetcroja® (cefiderocol), an innovative siderophore cephalosporin at the 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases in Vienna on 11th-15th April 2025.

7 April 2025 -- California, US -- Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced it has initiated its pivotal FORWARD CAD investigational device exemption (IDE) study. Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.